Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy

ObjectiveThe present study aimed to evaluate the predictive factors that predict outcomes of HER2-low breast cancer patients who did not achieve pathological complete response(pCR) after neoadjuvant chemotherapy (NAC).MethodsThis study included patients with HER2-low breast cancer who received NAC f...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yingbo Shao, Huijuan Guan, Zhifen Luo, Yang Yu, Yaning He, Qi Chen, Chaojun Liu, Fangyuan Zhu, Hui Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-03-01
Edice:	Frontiers in Oncology
Témata:	breast cancer neoadjuvant chemotherapy HER2-low expression pathological complete response prognosis
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1459444/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!